{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:15:00Z","timestamp":1790673300167,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771744"],"award-info":[{"award-number":["81771744"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.intimp.2019.106035","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:44:24Z","timestamp":1574124264000},"page":"106035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["CXCL16\/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K\/AKT\/FOXO3a pathway"],"prefix":"10.1016","volume":"81","author":[{"given":"Zhenzhen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2019.106035_b0005","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/jama.285.5.648","article-title":"Prospects for autoimmune disease: research advances in rheumatoid arthritis","volume":"285","author":"Koopman","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.intimp.2019.106035_b0010","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.autrev.2013.05.001","article-title":"Lung involvement in connective tissue diseases: a comprehensive review and a focus on rheumatoid arthritis","volume":"12","author":"Marigliano","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2019.106035_b0015","first-page":"217","article-title":"Increased serum KL-6 levels induced by pulmonary mycobacterium Avium complex infection in a patient with RA-associated lung disease","volume":"70","author":"Waseda","year":"2016","journal-title":"Acta Med. Okayama"},{"issue":"1","key":"10.1016\/j.intimp.2019.106035_b0020","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/thorax.58.1.52","article-title":"High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia","volume":"58","author":"Ishii","year":"2003","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.intimp.2019.106035_b0025","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2019.106035_b0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clim.2014.08.004","article-title":"Anti-citrullinated heat shock protein 90 antibodies identified in bronchoalveolar lavage fluid are a marker of lung-specific immune responses","volume":"155","author":"Harlow","year":"2014","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2019.106035_b0035","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2013a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.intimp.2019.106035_b0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/art.38904","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2019.106035_b0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ijc.26007","article-title":"Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer","volume":"130","author":"Tanaka","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2019.106035_b0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10156-005-0416-9","article-title":"The role of serum KL-6 measurement in common pediatric respiratory infections","volume":"12","author":"Kubota","year":"2006","journal-title":"J. Infect. Chemother."},{"issue":"1","key":"10.1016\/j.intimp.2019.106035_b0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12931-016-0385-9","article-title":"Surfactant proteins, SP-A and SP-D, in respiratory fungal infections: their role in the inflammatory response","volume":"17","author":"Carreto-Binaghi","year":"2016","journal-title":"Respir. Res."},{"issue":"10","key":"10.1016\/j.intimp.2019.106035_b0060","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/thorax.58.10.872","article-title":"Circulating KL-6 levels in patients with drug induced pneumonitis","volume":"58","author":"Ohnishi","year":"2003","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.intimp.2019.106035_b0065","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1186\/ar2766","article-title":"Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients","volume":"11","author":"Schmidt","year":"2009","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2019.106035_b0070","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1172\/JCI30562","article-title":"The role of CXC chemokines in pulmonary fibrosis","volume":"117","author":"Strieter","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.intimp.2019.106035_b0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1189\/jlb.1003465","article-title":"Cell surface-anchored SR-PSOX\/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells","volume":"75","author":"Shimaoka","year":"2004","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2019.106035_b0080","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/intimm\/dxm083","article-title":"CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes","volume":"19","author":"Tohyama","year":"2007","journal-title":"Int. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2019.106035_b0085","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/HYPERTENSIONAHA.113.01837","article-title":"Critical role of CXCL16 in hypertensive kidney injury and fibrosis","volume":"62","author":"Xia","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.intimp.2019.106035_b0090","doi-asserted-by":"crossref","first-page":"28715","DOI":"10.1038\/srep28715","article-title":"CXCL16 deficiency attenuates renal injury and fibrosis in salt-sensitive hypertension","volume":"6","author":"Liang","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2019.106035_b0095","doi-asserted-by":"crossref","first-page":"H815","DOI":"10.1152\/ajpheart.00948.2015","article-title":"CXCL16 regulates renal injury and fibrosis in experimental renal artery stenosis","volume":"311","author":"Ma","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"10.1016\/j.intimp.2019.106035_b0100","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/ATVBAHA.113.303172","article-title":"CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis","volume":"34","author":"Xia","year":"2014","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2019.106035_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030113","article-title":"Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids","volume":"3","author":"Geissmann","year":"2005","journal-title":"PLoS Biol."},{"issue":"10","key":"10.1016\/j.intimp.2019.106035_b0110","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis","volume":"190","author":"Wehr","year":"2013","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2019.106035_b0115","first-page":"6514","article-title":"CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-alpha-dependent MMP9 pathway","volume":"7","author":"Wang","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"9","key":"10.1016\/j.intimp.2019.106035_b0120","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3899\/jrheum.090108","article-title":"Serum CXCL16 concentrations correlate with the extent of skin sclerosis in patients with systemic sclerosis","volume":"36","author":"Yanaba","year":"2009","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2019.106035_b0125","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/art.21301","article-title":"Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis","volume":"52","author":"Nanki","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.intimp.2019.106035_b0130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00011-015-0905-y","article-title":"CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2\/STAT3 and p38\/MAPK signaling pathway","volume":"65","author":"Li","year":"2016","journal-title":"Inflamm. Res."},{"issue":"2","key":"10.1016\/j.intimp.2019.106035_b0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S2213-2600(17)30433-2","article-title":"Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper","volume":"6","author":"Lynch","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.intimp.2019.106035_b0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4187\/respcare.01503","article-title":"PFT interpretive strategies: American Thoracic Society\/ European Respiratory Society 2005 guideline gaps","volume":"57","author":"Miller","year":"2012","journal-title":"Respir. Care"},{"issue":"5","key":"10.1016\/j.intimp.2019.106035_b0145","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.intimp.2019.106035_b0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2019.106035_b0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2019.106035_b0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1755-1536-5-11","article-title":"Molecular and cellular mechanisms of pulmonary fibrosis","volume":"5","author":"Todd","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"51\u201352","key":"10.1016\/j.intimp.2019.106035_b0165","first-page":"875","article-title":"The diagnosis and treatment of idiopathic pulmonary fibrosis","volume":"110","author":"Behr","year":"2013","journal-title":"Dtsch Arztebl. Int"},{"issue":"6","key":"10.1016\/j.intimp.2019.106035_b0170","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00005-015-0356-8","article-title":"The role of CXC chemokines in pulmonary fibrosis of systemic lupus erythematosus patients","volume":"63","author":"Nielepkowicz-Gozdzinska","year":"2015","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"11","key":"10.1016\/j.intimp.2019.106035_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049278","article-title":"CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis","volume":"7","author":"Gharaee-Kermani","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2019.106035_b0180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1165\/rcmb.2006-0187OC","article-title":"Role of the SDF-1\/CXCR4 axis in the pathogenesis of lung injury and fibrosis","volume":"37","author":"Xu","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2019.106035_b0185","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1172\/JCI200420997","article-title":"Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis","volume":"114","author":"Phillips","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.intimp.2019.106035_b0190","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1164\/rccm.201309-1592OC","article-title":"C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis","volume":"189","author":"Vuga","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9","key":"10.1016\/j.intimp.2019.106035_b0195","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/thoraxjnl-2015-207682","article-title":"CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis","volume":"72","author":"Jia","year":"2017","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.intimp.2019.106035_b0200","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/art.21004","article-title":"Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints","volume":"52","author":"Van Der Voort","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.intimp.2019.106035_b0205","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/j.1365-2222.2005.02383.x","article-title":"Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease","volume":"35","author":"Morgan","year":"2005","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.intimp.2019.106035_b0210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1164\/rccm.201212-2297OC","article-title":"Role of lung pericytes and resident fibroblasts in the pathogenesis of pulmonary fibrosis","volume":"188","author":"Hung","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2019.106035_b0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1164\/rccm.201002-0279OC","article-title":"An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor beta receptor","volume":"183","author":"Hoyles","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2019.106035_b0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fmed.2017.00118","article-title":"Exploring animal models that resemble idiopathic pulmonary fibrosis","volume":"4","author":"Tashiro","year":"2017","journal-title":"Front Med. (Lausanne)"},{"issue":"23","key":"10.1016\/j.intimp.2019.106035_b0225","doi-asserted-by":"crossref","first-page":"16239","DOI":"10.1074\/jbc.M113.542407","article-title":"Regulation of TGF-beta1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C","volume":"289","author":"Kasabova","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2019.106035_b0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2014.12.034","article-title":"Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K\/Akt\/FoxO3a signalling in experimental colon cancer","volume":"359","author":"Qazi","year":"2015","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.intimp.2019.106035_b0235","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3346\/jkms.2014.29.2.230","article-title":"Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction: the role of PI3K-Akt-FoxO3a signaling","volume":"29","author":"Yoon","year":"2014","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.intimp.2019.106035_b0240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/s12967-015-0699-2","article-title":"Cyclic helix B peptide inhibits ischemia reperfusion-induced renal fibrosis via the PI3K\/Akt\/FoxO3a pathway","volume":"13","author":"Yang","year":"2015","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2019.106035_b0245","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1074\/jbc.M311660200","article-title":"CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation","volume":"279","author":"Chandrasekar","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919315231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919315231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:15:55Z","timestamp":1761585355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919315231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":49,"alternative-id":["S1567576919315231"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106035","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CXCL16\/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K\/AKT\/FOXO3a pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.106035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106035"}}